NeoGenomics, Inc.
neogenomics.com ↗In their words
“Our net promoter score of 79 reflects strong physician satisfaction among our current customer base with our NPS score continuing to improve in 2025, even with record test volumes.”
“The trust our partners have in us to deliver on turnaround time and meet our commitments has once again improved our Net Promoter Score to 74 in 2024, up from 70 in 2023.”
“As a result of our increased coverage, clinical support, and patient-centric mentality, we maintained our customer experience leadership in the market with a three point improvement in net promoter score, which is now at 70.”
Disclosed NPS over time
Every Net Promoter Score NeoGenomics, Inc. has published, by date.
NPS disclosures (29)
NeoGenomics reported Net Promoter Scores in the high 70s across both segments as it expands its commercial representative force.
NeoGenomics achieved a Net Promoter Score of 78 in a June 2026 study.
They also lead to an industry-leading customer experience as evidenced by our Net Promoter Score in the high 70s across both pathology and oncology.
Improved our Net Promoter Score to 79, up from 74 in 2024, reflecting strong physician satisfaction among our current customer base 2025 Annual Report — 3 $ in Thousands 2022 2023 2024 2025 Revenue $509,728 $591,643 $660,566 $727,332 % Growth 5.2% 16.1%…
Our net promoter score of 79 reflects strong physician satisfaction among our current customer base with our NPS score continuing to improve in 2025, even with record test volumes.
…Improved our Net Promoter Score to 74, up from 70 in 2023 •
The trust our partners have in us to deliver on turnaround time and meet our commitments has once again improved our Net Promoter Score to 74 in 2024, up from 70 in 2023.
As a result of our increased coverage, clinical support, and patient-centric mentality, we maintained our customer experience leadership in the market with a three point improvement in net promoter score, which is now at 70.
Our latest Net Promoter Score Survey yielded a 62, continuing our track record of delivering elite service levels to our customers. We are proud of the quality of the service that our teams continued to deliver during the year.
I’m also pleased to share that Neo again achieved a net promoter score in excess of 60, a world-class result. I want to thank our committed employees, who are the key to our strong customer relationships and our track record of delivering elite service.
…and appropriate biomarkers leads to great care at a value We Are Focused on The Customer NOTES: 1,055 respondents 17 Best-in-class net promoter score Q4 2020 Clinical Client Survey How likely is it that you would recommend this company to a friend or…
This consistent dedication has translated into industry leading turnaround times in many of our test modalities and is also reflected in both our strong Net Promoter Scores and the extremely high customer retention rate.
…and appropriate biomarkers leads to great care at a value We Are Focused on The Customer NOTES: 1,055 respondents 16 Best-in-class net promoter score Q4 2020 Clinical Client Survey How likely is it that you would recommend this company to a friend or…
• Improved net promoter score to 67; • Achieved Clinical revenue growth of approximately 6% in a COVID impacted environment.
…biomarkers leads to great care at a value Exhibit 99.1 We Are Focused on The Customer NOTES: 1,055 respondents 16 Best-in-class net promoter score Q4 2020 Clinical Client Survey How likely is it that you would recommend this company to a friend or…
…And Appropriate Biomarkers Leads To Great Care At A Value We Are Focused on The Customer NOTES: 1,055 respondents 17 Best in Class Net Promoter Score Q4 2020 Clinical Client Survey How likely is it that you would recommend this company to a friend or…
…year-over-year 39% year-over-year Q3 of 2020 increase in backlog Pharma revenue growth 12 Focused on Customer Satisfaction Net Promoter Score Q2 2020 Clinical Client Survey How likely is it that you would recommend this company to a friend or colleague?
Not at all likely Neutral Extremely likely 0 0 1 2 3 4 5 6 7 8 9 10 -50 50 Detractor Passive Promoter +67 NPS 7% 19% 74% -100 100 % Promoters - % Detractors = NPS ( Net Promoter Score) NOTES: 1,423 respondents 28 questions + comments 13 Culture Is At…
We surveyed clients in the midst of the pandemic and received our highest response rate and highest score ever with a score that is nearly tenfold higher than the average score for our peer group.
Not at all likely Neutral Extremely likely 0 0 1 2 3 4 5 6 7 8 9 10 -50 50 Detractor Passive Promoter +60 NPS 7% 26% 67% -100 100 % Promoters - % Detractors = NPS ( Net Promoter Score) NOTES: Survey Period: November 11th, 2019 to January 10th, 2020 951…
…Q4 adding $12M to backlog increase in backlog Pharma revenue growth sequentially 12 Focused on Customer Satisfaction Net Promoter Score Q1 2020 Clinical Client Survey How likely is it that you would recommend this company to a friend or colleague?
…in diluted shares — — Adjusted diluted shares outstanding (non-GAAP) 104,500 104,500 26 Focused on Customer Satisfaction Net Promoter Score Q2 2019 Clinical Client Survey How likely is it that you would recommend this company to a friend or colleague?
…4,000 — Adjusted diluted shares outstanding (non-GAAP) 104,500 104,500 27 Exhibit 99.1 Focused on Customer Satisfaction Net Promoter Score Q2 2019 Clinical Client Survey How likely is it that you would recommend this company to a friend or colleague?
…stock-based compensation 2,139 1,624 Adjusted EBITDA (non-GAAP) $ 13,759 $ 9,238 26 Focused on Customer Satisfaction Net Promoter Score Q4 2018 Clinical Client Survey How likely is it that you would recommend this company to a friend or colleague?
Client satisfaction for both divisions, measured by Net Promoter Scores, were considered world class, and client retention rates continued to be above 98%.
We are quite proud that with approximately 2000 responses to our customer surveys during 2018, our net promoter scores ranged from 59 to 60.
…LDT & IVD assays 10 Net Promoter Score Overview: • Survey Opened June 4th •
Our Net Promoter Score or NPS was a record high 54. You may be aware of the Net Promoter Score; it was developed by Bain & Company, and is a tool for gauging the loyalty of a firm's customer relationships.
Our customer survey results the other day -- we measure something call the Net Promoter Score. Many of our clients rated us very, very highly and are essentially promoters of our service.
Retention disclosures (4)
Neo4j reported impressive global customer retention and growth in 2020, with a customer base of almost 800 across numerous industries.
Retention rate: 97% (Q4 2018) — “our retention rate of customers is in the very high 90 and we don't expect to lose customers”
NeoGenomics reported an overall customer retention rate of 97.5 percent in 2017.
Retention rate: 97.5% (Q4 2017) — “our overall customer retention rate during the past year was 97.5%”
Lighthouse companies in Pharma, medtech & health distribution
About these figures
Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.
NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.